Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
D000368:Aged; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004967:Estrogens / Q000494:pharmacology*; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism; D006242:Haptoglobins / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000494:pharmacology*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy; D013997:Time Factors
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D006242:Haptoglobins; D004054:Diethylstilbestrol; D005340:Fibrinogen; D008525:Medroxyprogesterone; D006854:Hydrocortisone